{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:12:07Z","timestamp":1790478727178,"version":"4.1.0"},"reference-count":52,"publisher":"The Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10,1]]},"DOI":"10.1210\/jc.2007-0620","type":"journal-article","created":{"date-parts":[[2007,7,18]],"date-time":"2007-07-18T00:33:26Z","timestamp":1184718806000},"page":"3844-3853","source":"Crossref","is-referenced-by-count":186,"title":["Androgen Receptor Gene CAG Repeat Length and Body Mass Index Modulate the Safety of Long-Term Intramuscular Testosterone Undecanoate Therapy in Hypogonadal Men"],"prefix":"10.1210","volume":"92","author":[{"given":"Michael","family":"Zitzmann","sequence":"first","affiliation":[{"name":"Institute of Reproductive Medicine, University Clinics, Muenster D-48149, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Nieschlag","sequence":"additional","affiliation":[{"name":"Institute of Reproductive Medicine, University Clinics, Muenster D-48149, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113582182600_R1","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1210\/jc.2005-2847","article-title":"Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline.","volume":"91","author":"Bhasin","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582182600_R2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/humupd\/dmh035","article-title":"Testosterone replacement therapy: current trends and future directions.","volume":"10","author":"Nieschlag","year":"2004","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t2019041113582182600_R3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2265.2006.02618.x","article-title":"Testosterone treatment comes of age: new options for hypogonadal men.","volume":"65","author":"Nieschlag","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113582182600_R4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2605.2005.00553.x","article-title":"Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations.","volume":"28","author":"Nieschlag","year":"2005","journal-title":"Int J Androl"},{"key":"key\n\t\t\t\t2019041113582182600_R5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2265.2005.02339.x","article-title":"Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis.","volume":"63","author":"Isidori","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113582182600_R6","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/gerona\/60.11.1451","article-title":"Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials.","volume":"60","author":"Calof","year":"2005","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"key\n\t\t\t\t2019041113582182600_R7","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1530\/eje.0.1400414","article-title":"Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies.","volume":"140","author":"Behre","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113582182600_R8","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1046\/j.1365-2265.1999.00881.x","article-title":"Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men.","volume":"51","author":"Nieschlag","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113582182600_R9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/j.1939-4640.2002.tb02249.x","article-title":"Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study.","volume":"23","author":"von Eckardstein","year":"2002","journal-title":"J Androl"},{"key":"key\n\t\t\t\t2019041113582182600_R10","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/j.1939-4640.2003.tb02739.x","article-title":"Pharmacokinetics and degree of aromatization rather than total dose of different preparations determine the effects of testosterone: a nonhuman primate study in Macaca fascicularis.","volume":"24","author":"Weinbauer","year":"2003","journal-title":"J Androl"},{"key":"key\n\t\t\t\t2019041113582182600_R11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-0684.2005.00115.x","article-title":"Pharmacokinetics and pharmacodynamics of injectable testosterone undecanoate in castrated cynomolgus monkeys (Macaca fascicularis) are independent of different oil vehicles.","volume":"34","author":"Wistuba","year":"2005","journal-title":"J Med Primatol"},{"key":"key\n\t\t\t\t2019041113582182600_R12","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1210\/jc.2004-0897","article-title":"Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism.","volume":"89","author":"Schubert","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582182600_R13","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1517\/14656566.6.10.1751","article-title":"Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism.","volume":"6","author":"Harle","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"key\n\t\t\t\t2019041113582182600_R14","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1210\/jc.2006-0822","article-title":"Differences in the apparent metabolic clearance rate of testosterone in young and older men with gonadotropin suppression receiving graded doses of testosterone.","volume":"91","author":"Coviello","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582182600_R15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1365-2605.2003.00393.x","article-title":"The CAG repeat polymorphism within the androgen receptor gene and maleness.","volume":"26","author":"Zitzmann","year":"2003","journal-title":"Int J Androl"},{"key":"key\n\t\t\t\t2019041113582182600_R16","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1210\/jc.2002-021947","article-title":"Prostate volume and growth in testosterone-substituted hypogonadal men are dependent on the CAG repeat polymorphism of the androgen receptor gene: a longitudinal pharmacogenetic study.","volume":"88","author":"Zitzmann","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582182600_R17","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1210\/jc.2004-1424","article-title":"X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients.","volume":"89","author":"Zitzmann","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582182600_R18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.0022-202X.2005.10123.x","article-title":"Effectiveness of finasteride on patients with male pattern baldness who have different androgen receptor gene polymorphism.","volume":"10","author":"Wakisaka","year":"2005","journal-title":"J Investig Dermatol Symp Proc"},{"key":"key\n\t\t\t\t2019041113582182600_R19","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1210\/jc.2006-0401","article-title":"Association of specific symptoms and metabolic risks with serum testosterone in older men.","volume":"91","author":"Zitzmann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582182600_R20","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum.","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582182600_R21","volume-title":"Andrology: male reproductive health and dysfunction","author":"Behre","year":"2000","edition":"2nd ed"},{"key":"key\n\t\t\t\t2019041113582182600_R22","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/jc.2003-032006","article-title":"Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.","volume":"89","author":"Wang","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582182600_R23","doi-asserted-by":"crossref","first-page":"E1172","DOI":"10.1152\/ajpendo.2001.281.6.E1172","article-title":"Testosterone dose-response relationships in healthy young men","volume":"281","author":"Bhasin","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582182600_R24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1017\/CBO9780511545221.003","article-title":"The androgen receptor: molecular biology","author":"Klocker","year":"2004","journal-title":"In: Nieschlag E, Behre HM, eds. Testosterone: action, deficiency, substitution. 3rd ed. Cambridge, UK: Cambridge University Press;"},{"key":"key\n\t\t\t\t2019041113582182600_R25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ng1093-184","article-title":"Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy.","volume":"5","author":"Mhatre","year":"1993","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t2019041113582182600_R26","doi-asserted-by":"crossref","first-page":"20229","DOI":"10.1074\/jbc.274.29.20229","article-title":"The linkage of Kennedy\u2019s neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator.","volume":"274","author":"Hsiao","year":"1999","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041113582182600_R27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/hmg\/9.2.267","article-title":"Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length.","volume":"9","author":"Irvine","year":"2000","journal-title":"Hum Mol Gen"},{"key":"key\n\t\t\t\t2019041113582182600_R28","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1001\/archinte.166.15.1660","article-title":"Low serum testosterone and mortality in male veterans.","volume":"166","author":"Shores","year":"2006","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113582182600_R29","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer.","volume":"24","author":"Keating","year":"2006","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019041113582182600_R30","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.amjmed.2005.10.048","article-title":"Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study.","volume":"119","author":"Amin","year":"2006","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019041113582182600_R31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1365-2265.1999.00705.x","article-title":"Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7\u201310 years.","volume":"50","author":"Behre","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113582182600_R32","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1001\/jama.296.19.2351","article-title":"Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.","volume":"296","author":"Marks","year":"2006","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113582182600_R33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2265.1994.tb03929.x","article-title":"Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls.","volume":"40","author":"Behre","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113582182600_R34","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1017\/CBO9780511545221.010","volume-title":"Testosterone: action, deficiency, substitution","author":"Zitzmann","year":"2004","edition":"3rd ed"},{"key":"key\n\t\t\t\t2019041113582182600_R35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1053\/beha.1999.0035","article-title":"Rheological influences on thrombosis.","volume":"12","author":"Lowe","year":"1999","journal-title":"Baillieres Best Pract Res Clin Haematol"},{"key":"key\n\t\t\t\t2019041113582182600_R36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0140-6736(85)91414-X","article-title":"Platelet aggregation, haematocrit, and fibrinogen.","volume":"16","author":"Lowe","year":"1985","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113582182600_R37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2796.1994.tb01050.x","article-title":"Haematocrit, hypertension and risk of stroke.","volume":"235","author":"Wannamethee","year":"1994","journal-title":"J Intern Med"},{"key":"key\n\t\t\t\t2019041113582182600_R38","first-page":"145","article-title":"Yonsei Stroke Registry. Analysis of 1,000 patients with acute cerebral infarctions.","volume-title":"Cerebrovasc Dis","author":"Lee","year":"2001"},{"key":"key\n\t\t\t\t2019041113582182600_R39","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/j.1939-4640.2002.tb02272.x","article-title":"Contraceptive steroids influence the hemostatic activation state in healthy men.","volume":"23","author":"Zitzmann","year":"2002","journal-title":"J Androl"},{"key":"key\n\t\t\t\t2019041113582182600_R40","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1210\/jc.2004-1184","article-title":"Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle.","volume":"90","author":"Bhasin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582182600_R41","first-page":"3469","article-title":"Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men.","volume":"84","author":"Dobs","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582182600_R42","first-page":"1026","article-title":"Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system.","volume":"86","author":"Dobs","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582182600_R43","first-page":"156","article-title":"Testosterone and risk factors for cardiovascular disease in men.","volume":"21","author":"Barrett-Connor","year":"1995","journal-title":"Diabetes Metab"},{"key":"key\n\t\t\t\t2019041113582182600_R44","first-page":"2647","article-title":"Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age.","volume":"84","author":"Snyder","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582182600_R45","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1210\/jc.2003-031492","article-title":"Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men.","volume":"89","author":"Woodhouse","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113582182600_R46","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1291\/hypres.28.625","article-title":"Serum testosterone levels and arterial blood pressure in the elderly.","volume":"28","author":"Fogari","year":"2005","journal-title":"Hypertens Res"},{"key":"key\n\t\t\t\t2019041113582182600_R47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0021-9150(99)00055-6","article-title":"Obesity, mortality and cardiovascular disease in the Munster Heart Study (PROCAM).","volume":"144","author":"Schulte","year":"1999","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t2019041113582182600_R48","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1210\/me.2006-0021","article-title":"Replacing the mouse androgen receptor with human alleles demonstrates glutamine tract length-dependent effects on physiology and tumorigenesis in mice.","volume":"20","author":"Albertelli","year":"2006","journal-title":"Mol Endocrinol"},{"key":"key\n\t\t\t\t2019041113582182600_R49","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1365-2265.2005.02354.x","article-title":"Androgen receptor polymorphism (CAG repeats) and androgenicity.","volume":"63","author":"Canale","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113582182600_R50","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1158\/1055-9965.1765.13.11","article-title":"How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?","volume":"13","author":"Zeegers","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key\n\t\t\t\t2019041113582182600_R51","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0022-510X(96)00142-6","article-title":"Transcriptional activation by the androgen receptor in X-linked spinal and bulbar muscular atrophy.","volume":"142","author":"Nakajima","year":"1996","journal-title":"J Neurol Sci"},{"key":"key\n\t\t\t\t2019041113582182600_R52","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ncpuro0706","article-title":"Mechanisms of disease: pharmacogenetics of testosterone therapy in hypogonadal men.","volume":"4","author":"Zitzmann","year":"2007","journal-title":"Nat Clin Pract Urol"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/92\/10\/3844\/9051312\/jcem3844.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T15:36:40Z","timestamp":1737301000000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/92\/10\/3844\/2598090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,1]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2007-0620","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,1]]}}}